Burley Oak founder reflects on five years of craft beer and helping make Berlin cool
The Baltimore Sun

FDA approves reverse-anticoagulant drug Kcentra

When patients medicated for atrial fibrillation are brought to emergency departments with severe bleeding, reversing the effects of the anticoagulants they take can be difficult. The FDA has just approved a new product, Kcentra, for this purpose in some patients.
Lawrence K. Ho
Copyright © 2016, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad
90°